MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

MDT

87.56

+0.44%↑

A

114.42

-2.15%↓

VEEV

160

-7.43%↓

HQY

83.34

+1.87%↑

TLRY

6.65

-1.92%↓

Search

Cytek Biosciences Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

4.6 -2.75

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

4.45

Max

4.6899999999999995

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-39M

-44M

Pardavimai

9.8M

62M

Pelno marža

-70.929

Darbuotojai

702

EBITDA

4M

-263K

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+35.87% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-05-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

20M

581M

Ankstesnė atidarymo kaina

7.35

Ankstesnė uždarymo kaina

4.6

Naujienos nuotaikos

By Acuity

50%

50%

168 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

Cytek Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-08 20:44; UTC

Uždarbis

Costco Reports 11% Growth in March Sales

2026-04-08 23:51; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-08 23:51; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

2026-04-08 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Lower on Likely Technical Correction -- Market Talk

2026-04-08 22:56; UTC

Rinkos pokalbiai

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

2026-04-08 22:45; UTC

Rinkos pokalbiai

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

2026-04-08 22:17; UTC

Rinkos pokalbiai

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

2026-04-08 21:52; UTC

Svarbiausios naujienos

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

2026-04-08 21:24; UTC

Uždarbis

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

2026-04-08 21:01; UTC

Svarbiausios naujienos

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

2026-04-08 20:50; UTC

Rinkos pokalbiai

Energy & Utilities Roundup: Market Talk

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

2026-04-08 20:43; UTC

Įsigijimai, susijungimai, perėmimai

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

2026-04-08 20:42; UTC

Įsigijimai, susijungimai, perėmimai

Oracle Responds to TRC Cap Mini-Tender Offer

2026-04-08 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

2026-04-08 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

2026-04-08 19:44; UTC

Uždarbis

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

2026-04-08 19:16; UTC

Rinkos pokalbiai

Hogs Follow Cutout Prices Lower -- Market Talk

2026-04-08 19:02; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2026-04-08 19:02; UTC

Rinkos pokalbiai

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

2026-04-08 18:58; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

2026-04-08 18:51; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-08 18:51; UTC

Rinkos pokalbiai

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

2026-04-08 18:14; UTC

Svarbiausios naujienos

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

2026-04-08 18:05; UTC

Svarbiausios naujienos

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Cytek Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

35.87% į viršų

12 mėnesių prognozė

Vidutinis 6.25 USD  35.87%

Aukščiausias 7.5 USD

Žemiausias 5 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cytek Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

3.7 / 3.8Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

168 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat